Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MOUNTVIEW ESTATES PLC Board/Management Information 2019

Feb 25, 2019

4632_rns_2019-02-25_c22b0343-582c-444d-a893-4f53a4ec661d.html

Board/Management Information

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 0404R

Mountview Estates PLC

25 February 2019

FOR IMMEDIATE RELEASE - 25 February 2019

MOUNTVIEW ESTATES P.L.C.

Mountview Estates P.L.C.

("Mountview" or "the Company")

Directorate Changes

Mountview Estates P.L.C. announces that Tony Solway will step down, on 31 March 2019, from his role as Non-Executive Chairman and from the Board in the light of the results of the voting at the AGM and EGM in 2018. Tony Powell, currently a Non-Executive Director, will become Deputy Chairman with immediate effect and will assume the role of Acting Chairman on Tony Solway's departure pending the search for a suitable replacement. There are no other proposed changes to the Directors' roles. Further announcements will be made as appropriate.

Duncan Sinclair, Chief Executive Officer of Mountview, said:

"I would like to thank Tony for his contribution to the Company. He brought a significant amount of experience to the Board and we wish him every success in the future."

The information communicated in this announcement contains inside information for the purposes of Article 7 of Regulation 596/2014.

~Ends~

For further information on the Company, visit: www.mountviewplc.co.uk 

SPARK Advisory Partners Limited (Financial Adviser) www.Sparkadvisorypartners.com
Miriam Greenwood 0203 368 3553
Mark Brady 0203 368 3551

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

BOAPGUUCPUPBGWA